Department of Otorhinolaryngology, Head and Neck Surgery, Aarhus University Hospital, Denmark; Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark.
Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, Denmark.
Oral Oncol. 2024 Dec;159:107083. doi: 10.1016/j.oraloncology.2024.107083. Epub 2024 Oct 30.
Squamous cell carcinoma of unknown primary in the head and neck (HNSCCUP) remains a diagnostic challenge. Tongue base mucosectomy by transoral robotic surgery (TORS-TBM) can increase the diagnostic yield and de-intensify treatment. However, the added value of TORS-TBM as an adjunct to work-up programs for HNSCCUP is unclear. Furthermore, the optimal extent of the procedure and selection criteria remain to be established.
The primary aim of the present study was to assess the diagnostic yield of TORS-TBM as a supplement to a standardized work-up program, using the Danish national guidelines as an example. Secondary aims include predictive values of HPV-testing and PET/CT.
This was a national multicenter observational cohort study including all patients diagnosed with HNSCCUP from January 2013 to December 2019, who subsequently underwent TORS-TBM. In most cases HPV status was based on dual testing (p16 and HPV-DNA). Predictive values of PET/CT and HPV status were calculated.
A total of 100 consecutive patients underwent TORS-TBM; 93 total TBMs and 7 unilateral TBMs. The primary tumor was detected in 49 % (49/100) of patients. The detection rate was 58 % (47/81) in patients with HPV-associated disease (PPV of HPV status) and 11 % (2/19) in patients with HPV-independent disease. The NPV of HPV status was 89 %. The PPV and NPV of PET/CT was 53 % and 52 %, respectively.
Adding total TORS-TBM to the current Danish guideline-based work-up program on HNCCCUP patients with HPV-associated disease significantly improved the diagnostic yield.
头颈部不明原发灶的鳞状细胞癌(HNSCCUP)仍然是一个诊断难题。经口机器人手术(TORS-TBM)舌底黏膜切除术可提高诊断率并降低治疗强度。然而,TORS-TBM 作为 HNSCCUP 检查方案辅助手段的附加价值尚不清楚。此外,手术的最佳范围和选择标准仍有待确定。
本研究的主要目的是评估 TORS-TBM 作为标准化检查方案的补充,以丹麦国家指南为例,评估其诊断率。次要目的包括 HPV 检测和 PET/CT 的预测值。
这是一项全国多中心观察性队列研究,纳入了 2013 年 1 月至 2019 年 12 月期间所有被诊断为 HNSCCUP 的患者,这些患者随后接受了 TORS-TBM。在大多数情况下,HPV 状态基于双重检测(p16 和 HPV-DNA)。计算了 PET/CT 和 HPV 状态的预测值。
共有 100 例连续患者接受了 TORS-TBM;93 例全 TBM 和 7 例单侧 TBM。在 100 例患者中,49%(49/100)检测到原发性肿瘤。HPV 相关疾病患者的检出率为 58%(47/81)(HPV 状态的阳性预测值),HPV 无关疾病患者的检出率为 11%(2/19)。HPV 状态的阴性预测值为 89%。PET/CT 的阳性预测值和阴性预测值分别为 53%和 52%。
在 HPV 相关疾病的 HNSCCUP 患者中,在当前基于丹麦指南的检查方案中添加全 TORS-TBM 可显著提高诊断率。